Baseline and treatment-emergent bedaquiline resistance in drug-resistant tuberculosis: a systematic review and meta-analysis
Rubeshan Perumal, Neda Bionghi, Camus Nimmo, Marothi Letsoalo, Matthew J. Cummings, Madeleine Hopson, Allison Wolf, Shamim Al Jubaer, Nesri Padayatchi, Kogieleum Naidoo, Michelle H. Larsen, Max R. O’Donnell
Abstract
<h3>Tweetable abstract</h3> <b>Bedaquiline resistance is a major threat to drug-resistant tuberculosis control strategies. This analysis found a pooled prevalence of baseline bedaquiline resistance of 2.4% and a pooled prevalence of treatment-emergent bedaquiline resistance of 2.1%.</b> https://bit.ly/3FC6yio
Topics & Concepts
BedaquilineMedicineTuberculosisMeta-analysisDrug resistanceDrug resistant tuberculosisBaseline (sea)Multiple drug resistanceInternal medicineMycobacterium tuberculosisMicrobiologyPathologyBiologyFisheryTuberculosis Research and EpidemiologyPneumocystis jirovecii pneumonia detection and treatmentPneumonia and Respiratory Infections